-
LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial
Monday, May 9, 2022 - 7:48am | 340The FDA has lifted the clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) LB-001 Investigational New Drug Application (IND) to resume patient enrollment in Phase 1/2 SUNRISE trial in pediatric methylmalonic acidemia patients. Methylmalonic acidemia is an...
-
FDA Lifts Clinical Hold on LogicBio Therapeutics' IND for LB-001 in pediatric patients with Methylmalonic Acidemia
Monday, May 9, 2022 - 7:29am | 221The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on LogicBio Therapeutics’ (NASDAQ: LOGC) Investigational New Drug Application (IND) of its drug candidate LB-001 for pediatric patients with methylmalonic acidemia. This regulatory action allows patient...
-
80 Biggest Movers From Yesterday
Wednesday, May 4, 2022 - 4:04am | 2701Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to close at $1.83 after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging...
-
71 Biggest Movers From Yesterday
Wednesday, April 27, 2022 - 3:27am | 2399Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Nutex Health...
-
KeyBanc Sees Challenging Setup For Semiconductor Earnings
Wednesday, April 20, 2022 - 1:52pm | 943KeyBanc saw a challenging setup for semiconductor earnings season, as correction concerns dominated strong, broad-based near-term fundamentals and robust results and guidance. It saw a continued robust pricing environment and strong demand trends across auto, cloud data center, and 5G...
-
Here's How Goldman Sachs Views Microchip, AMD
Monday, March 28, 2022 - 5:31am | 258Goldman Sachs analyst Toshiya Hari downgraded Microchip Technology Inc (NASDAQ: MCHP) to Neutral from Buy with a $79 price target (2.4% upside). He sees supply tightness across its MCU, analog, and FPGA franchises to support sequential revenue growth through 2022....
-
Executives Buy More Than $1.5B Of 3 Stocks
Monday, March 14, 2022 - 7:00am | 487Although US stock futures traded higher this morning on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the...
-
54 Biggest Movers From Yesterday
Thursday, February 3, 2022 - 4:21am | 1882Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50. Great Panther Mining Limited (NYSE: GPL) surged 31% to close at $0.2075. Great Panther recently reported full year...
-
Here's Why UBS Is Bullish On Microchip Tech
Monday, January 31, 2022 - 11:41am | 180UBS analyst Pradeep Ramani upgraded Microchip Technology Inc (NASDAQ: MCHP) to Buy from Neutral with a price target of $92, up from $82, suggesting an upside of 21.5%. The analyst states that the Analog cycle is transitioning to the inventory build phase. However, it still...
-
3 Stocks Insiders Are Selling
Monday, December 27, 2021 - 9:17am | 446When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading...
-
46 Biggest Movers From Yesterday
Thursday, December 16, 2021 - 4:42am | 1735Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on Wednesday after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock. Biofrontera Inc. (...
-
Why Are Microchip Shares Trading Higher Today?
Wednesday, December 1, 2021 - 11:49am | 244Microchip Technology Inc (NASDAQ: MCHP) expanded its Gallium Nitride Radio Frequency power device portfolio with new MMICs and discrete transistors covering frequencies up to 20 gigahertz. The devices combine high power-added efficiency and high linearity to deliver new...
-
Pfizer COVID-19 Pill Adds Momentum to the Reopening Trade
Friday, November 5, 2021 - 9:13am | 2057The S&P 500 (SPX) and the Nasdaq Composite (COMP:GIDS) are trying to extend win streaks on Friday. The S&P 500 is up nearly 25% for the year and the Nasdaq is up nearly 24% for the year. The Employment Situation Report for October was released this morning showing that...
-
Chip Lead Times Continue To Slow, Hinting At Ease In Crisis: Bloomberg
Tuesday, October 26, 2021 - 5:34pm | 348Delivery times for chips in October posted their smallest gain in about nine months, signaling towards possible ease in crisis plaguing multiple industries, Bloomberg reports. The lead times, which implies the gap between a semiconductor order and delivery time, increased by one day to...
-
Analysts See Ample Upside In Microchip Technology
Thursday, October 14, 2021 - 9:14am | 259Stifel analyst Tore Svanberg initiated coverage of Microchip Technology Inc (NASDAQ: MCHP) with a Hold rating and a $76 Price Target, implying an 6% upside. With the shares up 156% from the pandemic lows, the analyst believes Microchip's "recent strong execution...